Bain Capital Life Sciences Fund, L.P. 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-08 4:49 pm Unchanged | 2022-08-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Bain Capital Life Sciences Fund, L.P. | 2,721,436 4.500% | 0 (Unchanged) | Filing |
| 2022-05-27 4:19 pm Sale | 2022-05-25 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Bain Capital Life Sciences Fund, L.P. | 2,721,436 5.300% | -888,360 (-24.61%) | Filing |
| 2021-02-08 5:00 pm Unchanged | 2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Bain Capital Life Sciences Fund, L.P. | 3,609,796 7.400% | 0 (Unchanged) | Filing |